Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minipress for Alcohol Dependence
NCT00762710Phase 2Completed
- Sponsor
- Seattle Institute for Biomedical and Clinical Research
- Start
- Jan 2008
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of prazosin in alcohol dependence, sponsored by Seattle Institute for Biomedical and Clinical Research. Primary endpoint: Alcohol Consumption at 12 weeks. Started Jan 2008; status: completed.
02
Drugs
prazosin
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00762710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00762710.